BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9234761)

  • 1. T-helper-cell cytokines in the early evolution of murine Lyme arthritis.
    Kang I; Barthold SW; Persing DH; Bockenstedt LK
    Infect Immun; 1997 Aug; 65(8):3107-11. PubMed ID: 9234761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.
    Ekerfelt C; Andersson M; Olausson A; Bergström S; Hultman P
    Clin Exp Immunol; 2007 Oct; 150(1):189-97. PubMed ID: 17672870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.
    Keane-Myers A; Nickell SP
    J Immunol; 1995 Aug; 155(4):2020-8. PubMed ID: 7636253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice.
    Zeidner N; Mbow ML; Dolan M; Massung R; Baca E; Piesman J
    Infect Immun; 1997 Aug; 65(8):3100-6. PubMed ID: 9234760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-interleukin 12 treatment on murine lyme borreliosis.
    Anguita J; Persing DH; Rincon M; Barthold SW; Fikrig E
    J Clin Invest; 1996 Feb; 97(4):1028-34. PubMed ID: 8613525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T helper phenotype and genetic susceptibility in experimental Lyme disease.
    Matyniak JE; Reiner SL
    J Exp Med; 1995 Mar; 181(3):1251-4. PubMed ID: 7869043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma interferon is not required for arthritis resistance in the murine Lyme disease model.
    Glickstein L; Edelstein M; Dong JZ
    Infect Immun; 2001 Jun; 69(6):3737-43. PubMed ID: 11349038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice.
    Ma Y; Seiler KP; Eichwald EJ; Weis JH; Teuscher C; Weis JJ
    Infect Immun; 1998 Jan; 66(1):161-8. PubMed ID: 9423853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection.
    Brown CR; Reiner SL
    Infect Immun; 1998 Nov; 66(11):5208-14. PubMed ID: 9784524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4-deficient BALB/c mice develop an enhanced Th1-like response but control cardiac inflammation following Borrelia burgdorferi infection.
    Satoskar AR; Elizondo J; Monteforte GM; Stamm LM; Bluethmann H; Katavolos P; Telford SR
    FEMS Microbiol Lett; 2000 Feb; 183(2):319-25. PubMed ID: 10675604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cells are activated during the early Th1 and Th2 immune responses in a murine Lyme disease model.
    Dong Z; Edelstein MD; Glickstein LJ
    Infect Immun; 1997 Dec; 65(12):5334-7. PubMed ID: 9393835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi.
    Ganapamo F; Dennis VA; Philipp MT
    Infect Immun; 2000 Dec; 68(12):7162-5. PubMed ID: 11083848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational attenuation of Lyme arthritis is mediated by progesterone and IL-4.
    Moro MH; Bjornsson J; Marietta EV; Hofmeister EK; Germer JJ; Bruinsma E; David CS; Persing DH
    J Immunol; 2001 Jun; 166(12):7404-9. PubMed ID: 11390492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes.
    Potter MR; Noben-Trauth N; Weis JH; Teuscher C; Weis JJ
    Infect Immun; 2000 Oct; 68(10):5603-9. PubMed ID: 10992460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon.
    Brown CR; Reiner SL
    Infect Immun; 1999 Jul; 67(7):3329-33. PubMed ID: 10377109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei.
    Ulett GC; Ketheesan N; Hirst RG
    Infect Immun; 2000 Apr; 68(4):2034-42. PubMed ID: 10722599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P
    J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
    Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
    J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania major infection in interleukin-4 and interferon-gamma depleted mice.
    Chatelain R; Mauze S; Varkila K; Coffman RL
    Parasite Immunol; 1999 Aug; 21(8):423-31. PubMed ID: 10417676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.